Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0PMVYF
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
EGFR-EDV-RRM1
|
|||||
| Synonyms |
EGFR-EDV-Dox; EGFR-EDV-PLK; Antibody-drug nanocell conjugates (EnGeneIC Pty Ltd.)
Click to Show/Hide
|
|||||
| Organization |
EnGeneIC Pty Ltd.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 1 Indication(s)
Glioblastoma [ICD11:2A00]
Phase 1
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Epidermal growth factor receptor (EGFR)
|
Antigen Info | ||||
| Payload Name |
Doxorubicin
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 2-alpha (TOP2A)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.